Kristin Price

Company: Guardant Health

Job title: Product Director

Seminars:

Panel Discussion & Q&A: Clinical Implication of Minimally Residual Disease (MRD) Diagnostics 1:35 pm

The objective of this session is to review and discuss the latest trends in Minimal Residual Disease (MRD) for the solid tumor space, focusing on key disease indications and the clinical data necessary for regulatory approval and healthcare provider adoption. Our panel will discuss the breadth of existing MRD data, the unmet clinical needs, and…Read more

day: Guardant Health Afternoon Workshop